Ainos, Inc. Files Definitive Proxy Statement

TL;DR

Ainos proxy statement is in, shareholders vote soon.

AI Summary

Ainos, Inc. filed its definitive proxy statement (DEF 14A) on August 15, 2024. The filing concerns the company's annual meeting and related matters. Ainos, Inc., formerly Amarillo Biosciences Inc., is incorporated in Texas and based in San Diego, California, operating in the pharmaceutical preparations sector.

Why It Matters

This filing provides shareholders with essential information regarding the company's governance, upcoming votes, and executive compensation, enabling informed participation in corporate decisions.

Risk Assessment

Risk Level: low — This is a routine proxy filing and does not contain new financial information or material events.

Key Players & Entities

• Ainos, Inc. (company) — Registrant
• Amarillo Biosciences Inc. (company) — Former company name
• San Diego, CA (location) — Company headquarters

FAQ

Filing Documents

• formdef14a.htm (DEF 14A) — 333KB
• proxy_001.jpg (GRAPHIC) — 279KB
• proxy_002.jpg (GRAPHIC) — 628KB
• 0001493152-24-032679.txt ( ) — 1584KB

Security ownership of certain beneficial owners

Security ownership of certain beneficial owners: Ainos Inc. (“Ainos KY”) (1) 3,056,898 38.00 %

Security ownership of management and directors

Security ownership of management and directors: Chun-Hsien Tsai (2) 302,319 3.76 % Chung-Yi Tsai (2) 52,932 * % Chun-Jung Tsai (2) 88,386 1.10 % Ting-Chuan Lee (2) 95,231 1.18 % Wen-Han Chang (3) 106,265 1.32 % Yao-Chung Chiang (4) 54,932 * % Pao-Sheng Wei 52,932 * % Meng-Lin Sung 61,050 * % Lawrence K. Lin (5) 22,098 * All Directors and Executive Officers as a Group (9 persons) 836,145 10.39 % *Represents beneficial ownership of less than 1% (1) Includes (i) 2,456,319 shares of common stock owned by Ainos KY; (ii) 482,168 shares of common stock pursuant to a Voting Agreement dated January 26, 2024 (the “2024 Voting Agreement”), by and among the Issuer, Ainos Inc., and Chun-Hsien Tsai, Ting-Chuan Lee, Chun-Jung Tsai, and Chung-Yi Tsai (the “Tsai Group”); (iii) 89,000 shares of common stock pursuant to a Voting Agreement dated March 7, 2024 (the “2024 Voting Agreement II”) with Chih-Heng Lu; and (iv) 29,411 shares owned by ASE Test. The voting agreement dated December 9, 2021 with Stephen T. Chen, Virginia M. Chen, the Stephen T. Chen and Virginia M. Chen Living Trust, dated April 12, 2018, and Hung Lan Lee terminated on January 26, 2024. Taiwan Carbon Nano Technology Corporation (TCNT) owns a majority of the outstanding voting securities of Ainos KY and, accordingly, may be deemed, for purposes of Section 13(d) of the Exchange Act, to share beneficial ownership of the shares of common stock held by Ainos KY. TCNT’s address is 10F-2, No. 66, Shengyi 5th Rd., Zhubei City, Hsinchu County 30261, Taiwan (R.O.C.). (2) Include restricted stock units that will vest within 60 days. (3) Includes 52,932 shares of common stock directly held by Wen-Han Chang, and 53,333 shares of common stock indirectly through his spouse, Chien-Hsuan Huang. (4) Includes 52,932 shares of common stock directly held by Yao-Chung Chiang, and 2,000 shares of common stock indirectly through his spouse, Hsi

View Full Filing

View this DEF 14A filing on SEC EDGAR